CLARIVATE PLC
$ 3.39
-3.14%
29 Dec - close price
- Market Cap 2,278,823,000 USD
- Current Price $ 3.39
- High / Low $ 3.49 / 3.38
- Stock P/E N/A
- Book Value 7.41
- EPS -0.55
- Next Earning Report 2026-02-18
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.01 %
- ROE -0.08 %
- 52 Week High 5.74
- 52 Week Low 3.04
About
Clarivate PLC is a prominent information services and analytics firm based in London, UK, specializing in the enhancement of scientific research and intellectual property management. The company provides an extensive suite of data-driven solutions and analytical tools that support researchers, academic institutions, and brands, enabling them to make informed decisions and drive innovation across multiple industries. With a strong focus on trademark and patent analytics, Clarivate plays a critical role in the global knowledge economy, solidifying its position as a strategic partner in advancing science and technology.
Analyst Target Price
$4.68
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-29 | 2025-07-30 | 2025-05-06 | 2025-02-25 | 2024-11-06 | 2024-08-06 | 2024-05-08 | 2024-02-27 | 2023-11-07 | 2023-08-03 | 2023-05-09 | 2023-03-01 |
| Reported EPS | 0.18 | -0.11 | 0.14 | 0.21 | 0.19 | 0.2 | 0.14 | 0.23 | 0.21 | 0.21 | 0.18 | 0.22 |
| Estimated EPS | 0.16 | 0.17 | 0.116 | 0.2024 | 0.19 | 0.18 | 0.14 | 0.21 | 0.18 | 0.2 | 0.15 | 0.17 |
| Surprise | 0.02 | -0.28 | 0.024 | 0.0076 | 0 | 0.02 | 0 | 0.02 | 0.03 | 0.01 | 0.03 | 0.05 |
| Surprise Percentage | 12.5% | -164.7059% | 20.6897% | 3.7549% | 0% | 11.1111% | 0% | 9.5238% | 16.6667% | 5% | 20% | 29.4118% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-18 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.13 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CLVT
2025-12-29 10:09:06
This article examines key global trademark filing trends impacting brand strategy for 2026, highlighting shifts in applicant nationalities, evolving foreign vs. domestic filing behaviors, and increasing concentration in cross-border protection. It emphasizes that IP teams must adapt their strategies by prioritizing data-driven decisions and adjusting to dynamic market conditions. Clarivate's SAEGIS platform is presented as a tool to navigate these changes effectively.
2025-12-28 12:46:00
Clarivate has introduced its Cortellis Regulatory Intelligence AI Assistant, an agentic AI-powered tool designed to streamline global safety workflows in life sciences. This assistant streamlines regulatory compliance by allowing users to ask complex questions in natural language, summarize documents, and compare guidance documents, thereby saving significant manual labor and accelerating decision-making throughout the product lifecycle. The tool leverages Clarivate’s established AI platform and over 30 years of regulatory expertise, aiming to transform how regulatory teams interpret global requirements into actionable insights.
2025-12-27 06:09:16
Clarivate (NYSE:CLVT) has been downgraded by Wall Street Zen from a "buy" to a "hold" rating, resulting in a new consensus rating of "Reduce" with a target price of $4.43. Despite the downgrade, significant insider buying has been noted, with directors acquiring millions of shares in recent months. The company's stock opened at $3.52 and maintains a market capitalization of $2.32 billion.
2025-12-25 23:09:06
Morgan Stanley downgraded Clarivate (CLVT) to Underweight, highlighting the company's slow turnaround, increasing AI competition, and tightening customer budgets. Despite trading at a discount to analyst targets, Clarivate has seen significant value destruction over the past five years, prompting questions about whether it's a contrarian bargain or accurately priced for muted future growth. The article discusses Clarivate's "undervalued" narrative, which relies on a sharp earnings swing and aggressive buybacks, along with AI-driven product innovation to enhance differentiation and margins.
2025-12-22 09:10:24
Derwent Patent Monitor is a new software solution designed to streamline Freedom to Operate (FTO) reviews and patent monitoring, eliminating fragmentation and improving risk management. It utilizes AI-powered threat analysis, project-based workflows, and integration with other Clarivate tools to accelerate decision-making and provide a clear audit trail. This solution aims to address the shortcomings of traditional manual patent monitoring methods by enhancing visibility, prioritization, and auditability.
2025-12-21 07:40:00
Morgan Stanley downgraded Clarivate Plc (CLVT) to Underweight and lowered its price target to $3, citing the company's struggling turnaround efforts, flat-to-low-single-digit growth guidance, and limited operating leverage. The firm also noted funding pressures in key sectors and increasing competitive pressure from AI. This contrasts with RBC Capital's earlier "Buy" rating and $5 price target, resulting in mixed analyst sentiment for CLVT.
